Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ibiayi Dagogo-Jack"'
Autor:
Satoshi Yoda, Wafa Malik, Adam Langenbucher, Justin F. Gainor, Sai-Hong Ignatius Ou, Kylie Prutisto-Chang, Ramin Sakhtemani, Jennifer L Peterson, Aaron N. Hata, Alexander Drilon, Andrew Do, Jessica J. Lin, Adam J. Schoenfeld, Viola W. Zhu, Ted William Johnson, Jochen K. Lennerz, Lecia V. Sequist, Noura J. Choudhury, Ibiayi Dagogo-Jack, Subba R. Digumarthy, Christina Falcon, Charlotte E. Lee, Alice T. Shaw, Michael S. Lawrence, Beow Y. Yeap, Jennifer S. Temel, Harper Hubbeling
Publikováno v:
Clin Cancer Res
Purpose: Current standard initial therapy for advanced, ROS proto-oncogene 1, receptor tyrosine kinase fusion (ROS1)-positive (ROS1+) non–small cell lung cancer (NSCLC) is crizotinib or entrectinib. Lorlatinib, a next-generation anaplastic lymphoma
Autor:
Scott L. Carter, Daniel P. Cahill, Pamela S. Jones, Brian V. Nahed, Albert E. Kim, Christopher Alvarez-Breckenridge, Ugonma Chukwueke, Wendy Y. Chen, Beth Overmoyer, Matthew R. Strickland, Deborah Forst, Joana L. Mora, Nancy Wang, Maura Mahar, Jorg Dietrich, Elizabeth R. Gerstner, April F. Eichler, Eudocia Q. Lee, Justine V. Cohen, Dejan Juric, Priscilla K. Brastianos, Michael White, Anita Giobbie-Hurder, Naema Nayyar, Helen A. Shih, Kevin S. Oh, Ryan J. Sullivan, Ibiayi Dagogo-Jack, Nan Lin, Aditya Bardia
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-7 (2021)
Nature Communications
Nature Communications
Leptomeningeal disease (LMD) is a common complication from solid tumor malignancies with a poor prognosis and limited treatment options. We present a single arm Phase II study of 18 patients with LMD receiving combined ipilimumab and nivolumab until
Autor:
Jochen K. Lennerz, Alice T. Shaw, Vashine Kamesan, Hayley Robinson, Ibiayi Dagogo-Jack, Mari Mino-Kenudson, A. John Iafrate, Anna F. Farago
Publikováno v:
Journal of Thoracic Oncology. 14:835-843
Lung cancer patients with tumors harboring actionable alterations can achieve very durable responses to first-line targeted therapy. However, identifying targetable alterations using next-generation sequencing (NGS) is a complex and time-intensive pr
Autor:
G. Petur Nielsen, Marina Kem, Athena L. Chen, Jochen K. Lennerz, Yin P Hung, Christopher G. Azzoli, Martin S. Taylor, Martin K. Selig, Richard L. Kradin, Tiffany Huynh, Mari Mino-Kenudson, Ibiayi Dagogo-Jack
Publikováno v:
HistopathologyReferences. 78(6)
Aims Nuclear protein in testis (NUT) carcinoma, an aggressive tumour driven by NUTM1 rearrangements, often involves the lung/mediastinum and shows squamous differentiation. We encountered an index patient with a thoracic NUT carcinoma diagnosed by mo
Autor:
Ibiayi Dagogo-Jack, Anderson H. Kuo, Eric W. Zhang, Marguerite Rooney, Alice T. Shaw, Subba R. Digumarthy
Publikováno v:
CancerReferences. 126(20)
Background Plasma genotyping is an emerging approach for the identification of genetic alterations mediating resistance to anaplastic lymphoma kinase (ALK)-targeted therapy. The authors reviewed plasma genotyping and imaging findings to assess the co
Autor:
Ashish Saxena, Smitha Menon, Alice T. Shaw, Adam J. Schoenfeld, Jochen K. Lennerz, Jessica J. Lin, Anna F. Farago, Angela Taber, Ibiayi Dagogo-Jack, Anne M. Traynor, Gregory J. Riely, Viola W. Zhu, Justin F. Gainor, Sai-Hong Ignatius Ou, Beow Y. Yeap, Lorin A. Ferris, Subba R. Digumarthy, Andrew J. Plodkowski
BACKGROUND: The second-generation ALK inhibitor alectinib recently demonstrated superior efficacy compared to the first-generation ALK inhibitor crizotinib in advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC), es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5223cc6ac7a83bbba2b0055adcb85b7
https://europepmc.org/articles/PMC6341982/
https://europepmc.org/articles/PMC6341982/
Autor:
Melissa Lynne Johnson, Long P. Le, Siraj M. Ali, Alexa B. Schrock, Aaron N. Hata, Jessica J. Lin, Jeffrey S. Ross, Anthony J. Iafrate, Satoshi Yoda, Vincent A. Miller, Philip J. Stephens, Beow Y. Yeap, Viola W. Zhu, Kyle Gowen, Justin F. Gainor, Sai-Hong Ignatius Ou, Ginger Y. Jiang, Christine M. Lovly, Alice T. Shaw, Ibiayi Dagogo-Jack, Nicholas A. Jessop
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36(12)
Purpose Advanced anaplastic lymphoma kinase ( ALK) fusion-positive non–small-cell lung cancers (NSCLCs) are effectively treated with ALK tyrosine kinase inhibitors (TKIs). However, clinical outcomes in these patients vary, and the benefit of TKIs i
Autor:
Mark G. Kris, Juliana Eng, Benjamin Izar, Emily Chin, Justin F. Gainor, Fernando C. Santini, David R. Jones, Jamie E. Chaft, Ibiayi Dagogo-Jack, Alice T. Shaw, Beow Y. Yeap
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 122
Objectives Reports of the prognostic significance of ALK-rearrangement in resected non-small cell lung cancer (NSCLC) have been contradictory. We aimed to determine the prognosis of early-stage ALK-positive lung cancers relative to KRAS- and EGFR-mut
A Retrospective Analysis of the Efficacy of Pembrolizumab in Melanoma Patients With Brain Metastasis
Autor:
Alice T. Shaw, Justin F. Gainor, Anita Giobbie-Hurder, Donald P. Lawrence, Ryan J. Sullivan, Michael Lanfranchi, Ibiayi Dagogo-Jack
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 40(3)
A total of 50% of patients with melanoma will develop brain metastasis (BM). Pembrolizumab was approved for treatment of metastatic melanoma on the basis of significant systemic antitumor activity. Because of low enrollment of patients with BM in pem
Autor:
Kathryn T. Bieging, Arun Khattri, Christopher D. Brown, Thomas Stricker, Everett E. Vokes, Ezra E.W. Cohen, Johannes Brägelmann, Tanguy Y. Seiwert, Mark W. Lingen, Kenneth R. Alexander, Megan E. McNerney, Zhixiang Zuo, M. El Dinali, Ravi Salgia, Kevin P. White, Michaela K. Keck, Masha Kocherginsky, Richard Longnecker, Ibiayi Dagogo-Jack
Publikováno v:
Oral Oncology. 49:525-533
summary Background: Oral cavity and in particular oral tongue cancers occur with a rising incidence in younger patients often lacking the typical risk factors of tobacco use, alcohol use, and human papilloma virus (HPV) infection. Their prognosis whe